Mon, October 16, 2023

David Westenberg Maintained (ADPT) at Buy with Decreased Target to $13 on, Oct 16th, 2023

David Westenberg of Piper Sandler, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Buy with Decreased Target from $14 to $13 on, Oct 16th, 2023.

David has made no other calls on ADPT in the last 4 months.



There is 1 other peer that has a rating on ADPT. Out of the 1 peers that are also analyzing ADPT, all agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tejas Savant of "Morgan Stanley" Maintained at Hold with Decreased Target to $13 on, Friday, August 4th, 2023